Plasmatology
Scope & Guideline
Advancing Plasma Science for a Brighter Future
Introduction
Aims and Scopes
- Biochemical Characterization:
Research focused on the biochemical properties and functional characteristics of plasma components, including growth factors, anticoagulants, and other proteins. - Clinical Applications:
Studies addressing the clinical use of plasma products in treating various conditions, including hematological diseases, immune disorders, and complications arising from treatments. - Innovative Therapeutic Strategies:
Exploration of new therapeutic approaches utilizing plasma, such as CRISPR technologies, plasma exchange techniques, and novel purification processes. - Public Health and Policy Insights:
Research evaluating the implications of plasma management in healthcare settings, including blood product utilization, health equity, and access to therapies. - Case Studies and Retrospective Analyses:
Detailed examinations of specific clinical cases or retrospective studies that provide insights into the effectiveness and challenges associated with plasma therapies.
Trending and Emerging
- Genetic and Molecular Approaches:
An increasing focus on genetic analysis and molecular mechanisms, such as CRISPR and other gene-editing technologies, showcases the integration of cutting-edge science into plasma therapy. - COVID-19 Related Research:
A significant rise in studies related to COVID-19, particularly the therapeutic use of convalescent plasma and vaccine-related antibody responses, reflects the pandemic's influence on plasma research. - Patient-Centric Studies:
A trend towards research that emphasizes patient outcomes, quality of life, and health equity indicates a growing recognition of the importance of patient perspectives in plasma-related therapies. - Interventional Studies:
There is a notable increase in clinical trials and interventional studies assessing the efficacy of plasma therapies for various diseases, highlighting a shift towards evidence-based practice in plasma medicine. - Public Health and Resource Management:
Emerging themes around the management of plasma resources, including ethical considerations and policy implications, suggest a growing emphasis on the systemic aspects of plasma utilization in healthcare.
Declining or Waning
- Historical Case Reports:
There has been a noticeable decrease in the publication of traditional case reports, as the journal appears to be focusing more on innovative research and broader clinical implications rather than isolated clinical narratives. - Basic Science Studies:
Research that delves into the fundamental science of plasma components without direct clinical application seems to be waning, possibly due to a preference for studies that bridge the gap between bench and bedside. - Exploratory Studies on Rare Conditions:
Investigations into less common plasma-related conditions or niche therapeutic applications are becoming less frequent, indicating a potential shift towards more prevalent clinical issues.
Similar Journals
Plasma
Exploring New Horizons in Engineering and PhysicsPlasma is a leading open-access journal published by MDPI, devoted to the exploration and advancement of knowledge in the fields of engineering, physics, and materials science. Established in 2018, this journal provides a vital platform for researchers, professionals, and students to disseminate original findings and critical reviews related to plasma science, its applications, and its interdisciplinary aspects. With an E-ISSN of 2571-6182, Plasma actively promotes open access to ensure that research is widely accessible, reinforcing its commitment to accelerating scientific communication and collaboration across global communities. The journal enjoys respectable rankings in Scopus, with a notable position in Engineering, Physics and Astronomy, and Materials Science categories, making it an essential resource for those seeking to remain at the forefront of plasma research. Covering a range of topics until 2024, Plasma invites cutting-edge contributions that push the boundaries of understanding in this dynamic field.
Mediterranean Journal of Hematology and Infectious Diseases
Unlocking insights in hematology and infectious diseases for global health.Mediterranean Journal of Hematology and Infectious Diseases is a distinguished open access journal published by MATTIOLI 1885, dedicated to advancing the field of hematology and infectious diseases. Since its inception in 2009, the journal has provided a platform for researchers and practitioners to disseminate innovative findings, foster scholarly discourse, and enhance our understanding of these critical medical disciplines. With an impact factor reflecting its scholarly influence, it is recognized in the Q3 quartile for both Hematology and Infectious Diseases categories as of 2023. The journal's commitment to open access ensures that high-quality research is accessible to a global audience, contributing to the improvement of clinical practices and public health. Located in Fidenza, Italy, the journal continues to support converged research efforts from 2010 to 2024, making it an essential resource for academics, clinicians, and students in the medical community.
JOURNAL OF PLASMA PHYSICS
Transforming ideas into groundbreaking plasma research.Welcome to the JOURNAL OF PLASMA PHYSICS, a premier publication dedicated to advancing understanding and research in the field of plasma physics. Published by Cambridge University Press, this journal has been a pivotal resource since its inception in 1967, supporting scholars and professionals engaged in the innovative exploration of plasma phenomena. With an impressive Q1 rating in Condensed Matter Physics, the journal not only holds a significant position in the academic community but also ranks within the top 50th percentile in the Scopus database. Although it currently does not offer open access, the journal provides a wealth of valuable research contributions aimed at fostering knowledge and collaboration among researchers, professionals, and students alike. The Journal of Plasma Physics is committed to publishing high-quality articles that push the boundaries of knowledge, ensuring its vital role in the ever-evolving landscape of physics research.
JOURNAL OF CLINICAL APHERESIS
Innovative Insights in Apheresis: Shaping the Future of HematologyJOURNAL OF CLINICAL APHERESIS, published by WILEY, serves as a premier platform for disseminating cutting-edge research in the specialized field of apheresis and its clinical applications. Established in 1982, this journal has been a vital resource for healthcare professionals, researchers, and students, focusing on innovative techniques, advancements in clinical practices, and the therapeutic use of apheresis in hematology and other medical disciplines. With an ISSN of 0733-2459 and E-ISSN 1098-1101, the journal is indexed in various databases, reflecting its solid academic reputation. Currently positioned in the Q3 quartile rankings for both Hematology and Miscellaneous Medicine categories, it offers insightful views into evolving methodologies and case studies that significantly impact patient care. Despite not being open access, the journal remains highly regarded within its community, ensuring that essential findings reach those dedicated to improving clinical outcomes in apheresis practices. Researchers and healthcare professionals are encouraged to engage with its comprehensive studies and foster further advancements in the field.
Plasma and Fusion Research
Pioneering Insights into the Future of Energy ProductionPlasma and Fusion Research is a pivotal journal within the realm of plasma science and nuclear fusion, published by the Japan Society of Plasma Science and Nuclear Fusion Research. With an ISSN of 1880-6821, this journal serves as a vital platform for disseminating significant research findings and advancements from Japan and around the globe. Operating since 2006, it has steadily contributed to the field, reflected in its recognition as a Q3 journal in Condensed Matter Physics for the year 2023 and its ranking of #383 out of 434 in the Scopus categories, placing it in the 11th percentile. Although it currently does not offer open access, the journal's commitment to quality research makes it essential reading for researchers, professionals, and students keen on exploring the complexities of plasma dynamics, fusion technology, and their applications in energy production. Situated in Nagoya, Japan, the journal fosters a collaborative environment aimed at pushing the boundaries of knowledge in plasma physics and enhancing the understanding of fusion processes.
VOX SANGUINIS
Elevating Knowledge in Hematology and MedicineVOX SANGUINIS is a distinguished peer-reviewed journal in the fields of Hematology and Medicine, published by Wiley, a leading academic publisher based in the United Kingdom. With a rich history dating back to its inception in 1952, this journal has consistently provided a platform for innovative research and insightful reviews, advancing the understanding of blood-related disorders and therapies. As evidenced by its robust performance—ranking #57 out of 137 in Scopus for Medicine in Hematology and holding a Q2 classification in both Hematology and miscellaneous Medicine categories—VOX SANGUINIS is recognized for its significant contributions to the scientific community. This journal serves as a vital resource for researchers, professionals, and students alike, fostering knowledge exchange and collaboration within the field. With its ongoing commitment to quality and integrity, VOX SANGUINIS continues to shape the future of hematological research well into 2024 and beyond.
Lancet Haematology
Transforming the future of hematology, one study at a time.Lancet Haematology, published by Elsevier Science Ltd in the United Kingdom, is a premier peer-reviewed journal dedicated to advancing the field of hematology. With an impressive impact factor and listed in the Q1 category in hematology for 2023, this journal ranks #4 out of 137 in the Scopus database, boasting a 97th percentile indicating its influential role in disseminating high-quality research. Since its establishment in 2014, Lancet Haematology has provided a vital platform for researchers and clinicians to share groundbreaking studies, innovative treatment approaches, and novel therapeutic discoveries relevant to various hematological disorders. The journal does not operate under an open access model, but it offers multiple access options to facilitate engagement with its content. By bridging clinical practice and cutting-edge research, Lancet Haematology aims to foster the advancement of knowledge and improve patient outcomes in hematology, making it an essential read for professionals, researchers, and students alike.
TRANSFUSION AND APHERESIS SCIENCE
Advancing the Frontiers of Hematology and Transfusion MedicineTRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.
HemaSphere
Fostering global collaboration in hematologic studies.HemaSphere, published by WILEY, stands at the forefront of hematology research, offering a vital platform for the dissemination of cutting-edge findings in the field. Since its inception in 2017 and official transition to Open Access in 2018, the journal has positioned itself as a leading conduit for high-impact research, maintaining a prestigious Q1 quartile ranking in the Hematology category as of 2023. Addressed in the United States at 111 River St, Hoboken, NJ, HemaSphere aims to foster a global dialogue among researchers, clinicians, and students by providing unrestricted access to high-quality content that encompasses clinical and experimental advancements. With an array of engaging articles, reviews, and commentaries, HemaSphere contributes significantly to the advancement of hematology, ensuring that critical knowledge is readily accessible to enhance patient care and innovative research. To explore the latest developments and breakthroughs in this dynamic field, we invite scholars, professionals, and students to engage with HemaSphere and elevate their understanding of hematologic science.
PLASMA PHYSICS REPORTS
Exploring Innovations in Plasma and BeyondPLASMA PHYSICS REPORTS, published by PLEIADES PUBLISHING INC, is a distinguished journal that caters to the intricate and evolving field of plasma physics and its applications within condensed matter physics and astronomy. With an ISSN of 1063-780X and an E-ISSN of 1562-6938, the journal serves as a pivotal platform for researchers, professionals, and students to disseminate groundbreaking work and foster collaboration among experts in the field. The journal operates as a non-open access resource, contributing to its reputation for curating high-quality research findings. Over its converged years from 1996 to 2024, the journal has established itself within the Q3 category across both condensed matter physics and miscellaneous physics and astronomy in the 2023 quartiles. With current Scopus rankings placing it in the 42nd percentile for physics and astronomy and the 27th percentile for condensed matter physics, PLASMA PHYSICS REPORTS stands as a vital resource for advancing knowledge and innovation in plasma research.